ABSTRACT: Crossbred steers (n = 180; 230 ± 6 kg) were fed during a 56-d receiving period to determine if supplementing chromium (Cr; KemTRACE Chromium Propionate 0.04%, Kemin Industries) would improve feedlot performance and health of newly-received cattle. A completely randomized block design (36 pens; 9 pens/treatment; 5 steers/pen) was used. Chromium premixes were supplemented to add 0 (Con), 0.1, 0.2, or 0.3 mg/kg of Cr to the total diet on a DM basis. No differences were detected on d 0 or after the fi rst 14 d on feed. From d 0 to d 28, DMI (P = 0.07) and ADG increased linearly (P = 0.04) as Cr concentrations increased. From d 0 to d 56, BW (P = 0.08) displayed a tendency to increase linearly, and consequently ADG and G:F increased linearly (P ≤ 0.05) as Cr concentrations increased. The number of steers treated at least once for respiratory symptoms tended (P = 0.07) to linearly decrease as Cr concentrations increased. Twenty additional steers (235 ± 4 kg) were fed 56 d to determine if supplementing Cr (Con or 0.2 mg/kg Cr) would alter the metabolic response of newly-received cattle to a lipopolysaccharide (LPS) challenge. Cattle were fi tted with jugular catheters on d 52. On d 55, blood samples were collected at 0.5-h intervals from −2 to 8 h, and again at 24 h relative to a LPS challenge (0.5 μg/ kg BW) at 0 h. Serum glucose, insulin, and NEFA concentrations were determined from blood samples. Steer BW was also measured at cannulation, and 24 h and 8 d post-LPS. Steer BW did not differ at cannulation (P = 0.37), but 24 h post-LPS, Cr-supplemented steers had lost less BW (P = 0.03). Pre-LPS glucose concentration did not differ (P = 0.97). Post-LPS, there was a time × treatment interaction (P < 0.01) such that glucose concentration peaked earlier (0.5 h) and at a greater concentrations in Cr-supplemented steers (P < 0.01). Insulin concentration did not differ between treatments pre-or post-LPS (P > 0.13). Concentration of NEFA did not differ pre-LPS (P = 0.54); but 0.5 h post-LPS Cr-treated steers produced a greater peak NEFA concentration (P < 0.04). Results of this study indicate that supplementation of Cr to the basal diet can have benefi cial effects on the performance and health of newly-received steers. These data also suggest that supplementation of Cr attenuated BW loss and allowed for a quicker recovery after a LPS challenge.
INTRODUCTION
Weaning, marketing, and handling associated with transportation events are extremely stressful on calves, and frequently lead to water and feed deprivation (Loerch and Fluharty, 1999) . These stressors negatively affect the immune system and increase the exposure of an animal to infectious agents. As a result, signifi cant increases in risk of morbidity and death loss are documented during the receiving period. Feed intake is decreased during initial exposure to concentrate rations, and stress further decreases feed consumption (Cole, 1996) to approximately 1.5% of BW during the fi rst 14 d after arrival (Galyean and Hubbert, 1995) . Reduced nutrient intake amplifi es the negative effects of stress on performance and immune function. In addition to vaccines and antibiotics, the industry has pursued the idea of nutritional supplementation as a mechanism to improve cattle health and performance.
Supplemented chromium (Cr) in various forms has been studied over the past 2 decades because of its involvement with glucose and insulin regulation. Chromium is an essential nutrient in animal nutrition that potentiates the action of insulin binding to insulin receptor sites (Kegley et al., 2000) . Cefalu et al. (2002) postulated that Cr picolinate augmented insulinsensitive glucose uptake by binding with chromodulin (Vincent, 2000) , which enhanced the translocation of glucose transporters to the cell membrane. In turn, this micro-mineral has been demonstrated to increase glucose clearance and insulin sensitivity (Kegley et al., 2000) , enhance performance (Moonsie-Shageer and , and alter the immune response (Chang and Mowat, 1992) of feeder calves. Consequently, the objectives of this study were 2-fold: 1) determine the impact of Cr on steer feedlot performance, morbidity, and mortality during a 56-d receiving period; and 2) determine if Cr affects glucose, insulin, or NEFA concentrations in response to a lipopolysaccharide (LPS) challenge.
MATERIALS AND METHODS
All procedures involving live animals were approved (#10027-05 and #10048-08) by the Texas Tech University Animal Care and Use Committee.
Performance Trial
Cattle. Two hundred and four cattle (steers and bulls; mainly British × Continental, with some American infl uence) were purchased in 2 equal loads (Group 1 received June 14, 2010, and Group 2 received June 21, 2010) from East Texas livestock auction barns, and transported (720 km) to the Texas Tech University Beef Center at New Deal, TX (off-truck average BW = 229 kg). The cattle were housed in dirt-lot pens with ad libitum access to sudangrass hay in the feed bunk overnight. The next 2 mornings, a 63% concentrate basal ration was fed on top of additional hay. No more hay was offered after the third day post-arrival. Initial processing of both groups (before feeding on June 17 and 23, 2010, respectfully) included 1) measurement of BW [Pearson squeeze chute, Thedford, NE; set on 4 electronic load cells (Gallagher Smart Scale Systems, North Kansas City, MO; readability of ± 0.90 kg); scales were calibrated with 454 kg of certifi ed weights (Texas Department of Agriculture) before use]; 2) placement in the ear of a uniquely numbered tag; 3) recording of phenotypic description; 4) vaccination with a modifi ed live virus vaccine (Tianium 3, Agri Laboratories, St. Joseph, MO) and clostridial bacterin toxoid (Vision 7 with SPUR, Merck Animal Health, Whitehouse Station, NJ); 5) treatment for internal parasites with Ivomec Plus (Merial, Duluth, GA); and 6) antibiotic treatment with Micotil (Elanco Animal Health, Greenfi eld, IN). Cattle were also implanted with Ralgro (36 mg of zeranol, Merck Animal Health) on d 0 (June 25).
Experimental Design, Treatment, and Pen Assignment. Group 1 was re-weighed on June 23 at the same time group 2 was processed, and these BW were used for stratifi cation. Twenty-four cattle were not used in the experiment because of sex, BW, temperament, or thriftiness, leaving 180 steers for use in the experiment (n = 180). Steers were blocked by BW and randomly assigned to a pen with the inclusion of at least 2 steers from each arrival group in each pen. Within a block, 4 treatments were assigned to pens in a completely randomized block design (36 pens; 9 pens/treatment; 4 pens/block; 5 steers/pen). Treatment diets included various levels of Cr based on the manufacturer recommendations: 1) control (Con; 0 mg/kg of Cr); 2) 0.1 mg/kg (provided 0.1 mg/kg of Cr to the entire diet, DM basis); 3) 0.2 mg/kg (provided 0.2 mg/kg of Cr to the entire diet, DM basis); or 4) 0.3 mg/kg (provided 0.3 mg/kg of Cr to the entire diet, DM basis). On d 0, initial BW was recorded and cattle were sorted into their home pen (3-m wide × 9.1-m pipe feedlot pens; with a dirt fl oor and concrete aprons around water troughs and feed bunks). Cattle were on feed for 56 d.
Management, Feeding, and Weighing. Estimates of the approximate quantity of unconsumed feed remaining in the feed bunk were made in each of the 36 pens from 0600 to 0615 h daily. Cattle were fed once daily in the morning (0700 to 0800 h) and adjustments in feed delivery for each pen were made to guarantee ad libitum access to feed, with the target being to leave from 0.0 to 0.5 kg of feed (per pen) in the bunk before the next daily feeding. The feeding order throughout the trial was in numerical pen order. Diets were mixed in a 1.27-m 3 -capacity paddle mixer (Marion Mixers Inc., Marion, IA) and transferred by a drag-chain conveyor to a mixer/delivery feed truck. Feed was augured out of the truck and weighed in a 189 L Rubbermaid trash barrel (which was previously tarred) on an Ohaus (Pine Brook, NJ) electronic balance (accuracy of ± 0.1 kg). The trash barrels were used to deliver the basal feed to each pen by hand. Cattle were fed a 63% concentrate diet from d 0 to 14. Concentrate level was increased at d 14 and d 28 (to 73 and 83% concentrate diets, respectfully). The 83% concentrate diet was fed for the remainder of the trial (d 28 to 56). Feed was offered at 95% of the delivery of the previous day on each transition day. Diets were formulated to meet or exceed NRC (1996) recommendations for nutrients (Table 1) .
All premixes were made at the Texas Tech University Burnett Center Feed Mill in a paddle type mixer (Marion Mixers Inc.). The supplement premix included standard trace minerals, vitamins, monensin (Rumensin, Elanco Animal Health) and tylosin (Tylan, Elanco Animal Health). Ingredients for the Cr premix included ground corn, corn oil, and Cr (Cr was excluded in the control premix). KemTrace Chromium Propionate (Kemin Industries, Des Moines, IA) was measured out into an individual clean bowl on a Mettler (Novatech UK Limited, Greenridge House, UK) electronic balance (accuracy ± 4.5 g). Corn oil was measured in a similar fashion. Ground corn was conveyed out of storage bins into a 189 L Rubbermaid trash barrel (which was previously tarred) on an Ohaus electronic balance (accuracy of ± 0.1 kg). The mixer was swept and blown out with pressurized air, then 45.4 kg of ground corn was run through the mixer for 3 min, and it was swept and blown out again before any premixes were made to remove any debris or contaminants that may have been present. The unloading door was shut before anything was poured into the mixer. Ground corn in its entirety was added fi rst, followed by corn oil, and fi nally the appropriate quantity of Cr. Corn oil and Cr were added as the mixer was running to ensure thorough mixing. The top lid on the mixer was shut and the premix was mixed for 5 min. Once mixing was fi nished, premixes were divided evenly into 4 labeled paper feed sacks (per treatment) through the bottom door of the mixer. Samples were taken from each premix and stored in plastic bags in the freezer (−20ºC) until sent to Servi-Tech Laboratories (Amarillo, TX) for total Cr analysis (Cr was measured by nitric acid/hydrogen peroxide digestion and inductively coupled plasma analysis). Analyzed concentrations of total Cr in the Cr premixes were 1.09 ± 0.344 mg/kg (Con), 5.84 ± 0.535 mg/kg (0.1 mg/kg), 12.23 ± 0.742 mg/kg (0.2 mg/kg), and 18.91 ± 1.093 mg/kg (0.3 mg/kg). Chromium premixes were made in this order to decrease likelihood of contamination: Con (0 mg/kg), 0.1 mg/kg, 0.2 mg/kg, 0.3 mg/kg. The mixer was swept and blown out with pressurized air between each premix to help decrease contamination. The Cr premixes were added at a rate of 2% (DM basis) of the bunk call (total feed delivered) made earlier that morning. Immediately after the feed was evenly poured into the bunks, the Cr premix was proportionally sprinkled across the top of the feed and mixed thoroughly by hand with an individual plastic scoop for each treatment. Diet samples were taken daily [1 sample/(treatment/day), from a random pen], composited weekly, and subsamples were stored in a freezer (−20ºC) until sent to Servi-Tech for analysis of chemical composition and total Cr (Table 2 ). Three diet samples were taken from each basal ration and 3 subsamples were dried in a forced-air oven at 100ºC for approximately 24 h to determine DM content. Weights for DM determination were taken on an Ohaus electronic balance (accuracy of ± 0.1g).
At approximately 0630 h on the morning of each weigh day (d 14, 28, 42, and 56) , the feed bunks were swept, unconsumed feed was collected and weighed, and 3 Chromium premix for the control treatment contained (DM basis): 98% ground corn and 2% corn oil.
4 Chromium premix for the 0.1 mg/kg treatment contained (DM basis): 96.75% ground corn, 2% corn oil, and 1.25% KemTrace Chromium Propionate 0.04% (Kemin Industries).
5 Chromium premix for the 0.2 mg/kg treatment contained (DM basis): 95.5% ground corn, 2% corn oil, and 2.5% KemTrace Chromium Propionate 0.04% (Kemin Industries).
6 Chromium premix for the 0.3 mg/kg treatment contained (DM basis): 94.25% ground corn, 2% corn oil, and 3.75% KemTrace Chromium Propionate 0.04% (Kemin Industries). a subsample of remaining feed was dried as described above to determine the DM content. The DMI by each pen was calculated by subtracting the quantity of dry feed unconsumed at the end of every 14 d from the total dietary DM delivered to each pen during that period. Individual BW measurements were obtained using the hydraulic squeeze chute described previously. Unshrunk BW were captured every 14 d, for 56 d before their daily feeding, between 0700 and 0900 h. On d 14, cattle were vaccinated again [Pyramid 2 plus Type II BVD, Pfi zer Animal Health, Kalamazoo, MI and Autogenous Bacterin (isolates included: Pasteurella multocida, Histophilus somni, Mannheimia haemolytica, and Mycoplasma bovis), Newport Laboratories, Worthington, MN]. Cattle health was evaluated daily between 0630 and 0700 h for physical symptoms of illness or lameness. Similar to Step et al. (2008) , subjective signs for illness encompassed abnormal appetite (entirely off feed, eating less than or with less aggression than expected, gaunt, or obvious BW loss); suggestion of depression (hanging head, sunken or glazed eyes, slow movement, arched back, struggle in rising, knuckling or dragging toes when walking, and stumbling); and respiratory signs (labored breathing, extended head and neck, and noise when breathing). Cattle were assigned a sickness score from 0 to 3. Zero represented no expression on the subjected signs listed above (healthy). If 1 or multiple signs were detected, the evaluator would assign a score from 1 to 3 based on the severity of the ailment, where 1 was very mild, 2 was moderate, 3 was severe. Cattle receiving a "1" were watched closely in subsequent days. Cattle receiving a "2" were pulled from their home pens and rectal temperature was measured. If the body temperature of the cattle was ≥ 39.7ºC they received an antimicrobial treatment [Resfl or GOLD (fl orfenicol and fl unixin meglumine, Merck Animal Health)] at a rate of 6 mL per 45.4 kg, subcutaneously. Steers assigned a '3' received an antimicrobial treatment (Resfl or GOLD) regardless of their rectal temperature. Cattle needing to be treated a second time for respiratory symptoms were treated the same as described above. If a third treatment was necessary for respiratory dysfunction, the cattle were treated with Draxxin (tulathromycin, Pfi zer Animal Health) at a rate of 1 mL per 40 kg, subcutaneously. Lame cattle were treated with Noromycin 300 LA (Oxytetracycline, Norbrooke Labs, Lenexa, KS) at a rate of 6 mL per 45.4 kg, subcutaneously and Banamine (fl unixin meglumine, Merck Animal Health) at a rate of 1 mL per 45.4 kg, intramuscularly. All cattle were immediately returned to their home pen after proper treatment. Daily treatment records were kept for later analysis of morbidity.
Statistical Analyses. All BW used for analysis were unshrunk BW. Data were tested to ensure that the assumption of normality of model residuals and sphericity was satisfi ed. All performance data were analyzed as a completely randomized block design using the MIXED procedure (SAS Inst. Inc., Cary, NC). Treatment was included as a fi xed effect and block was included as a random effect. Morbidity data were analyzed on a pen basis as binomial proportions using the GLIMMIX procedure of SAS. Three orthogonal contrasts were analyzed within the individual SAS programs for performance and morbidity: 1) Con vs. the average of the 3 Cr treatment groups; 2) linear effect when increasing the Cr concentration by 0.1 mg/kg from 0 mg/kg to 0.3 mg/kg; and 3) quadratic effect when increasing the Cr concentration by 0.1 mg/kg from 0 mg/kg to 0.3 mg/kg. An a priori hypothesis was also tested to contrast the differences between the least (Con) and greatest dose of Cr (0.3 mg/ kg). Means within tables are expressed as LS means. A P-value of ≤ 0.05 was considered signifi cant, and 0.05 > P ≤ 0.10 was considered a tendency.
LPS Challenge
Cattle. An additional 25 steers (British × Continental) were purchased at the Tulia livestock auction barn (Tulia, TX) to be used for a provocative LPS challenge. Steers were transported (105 km) to the Texas Tech University Beef Center at New Deal, Texas (off-truck average BW = 221 kg) on June 22. The cattle were housed in dirt-lot pens with ad libitum access to sudangrass hay in the feed bunk overnight. The next 2 mornings, a 63% concentrate basal ration was fed on top of additional hay. No more hay was offered after the third day post-arrival. Initial processing was conducted on June 23 and implantation on d 0 (June 25) as previously described.
Experimental Design, Treatment, and Pen Assignment. Processing BW were used for stratifi cation. Five steers were not used in the experiment because of BW, temperament, or thriftiness, leaving 20 steers for use in the experiment (n = 20). Steers were randomly assigned to 1 of 2 treatments: 1) Con (0 mg/kg of Cr); or 2) 0.2 mg/kg (provided 0.2 mg/kg of Cr to the entire diet, DM basis). On d 0, initial BW was recorded and cattle were sorted into their home pen as previously described. Management, Feeding, and Weighing. Steers were managed, fed, and weighed as previously described until d 52. On d 52, steers were weighed (cannulation BW) and fi tted with jugular vein catheters. For the cannulation procedure a small 2 to 3 cm incision was made in the skin to more easily access the jugular vein. Temporary indwelling jugular catheters consisting of approximately 30 cm of sterile Tygon tubing (AAQ04133; US Plastics, Lima, OH; 1.27 mm i.d. and 2.286 mm o.d.) was inserted into the jugular vein using a 14-gauge by 5.08 cm thin-walled stainless steel biomedical needle (o.d. = 3 mm). The catheter was maintained in place using tag cement and a 5.08 cm wide porous surgical tape around the incision site, and then the entire neck region of each steer was wrapped with Vet Wrap to ensure stability of the catheterization site. The remaining tubing not inserted into the steer served as the catheter extension for collection of blood samples. During these procedures steers were restrained in a working chute for approximately 10 to 15 min. After these procedures steers were moved to a facility that contained individual stalls (2.13-m long x 0.76-m wide) that housed the steers through the duration of the study. Steers were placed so that treatments alternated by stall. During the challenge the steers had ad libitum access to their respective treatment diets and water. The extension tubing of the catheter was extended above the stall to allow researchers to collect blood throughout the study without disturbing the steers. On d 55, whole blood samples (approximately 9 mL) were collected into blood tubes with no additives every 0.5 h beginning 2 h before and continuing 8 h after intravenous administration of LPS (0.5 μg/kg BW of LPS from Escherichia coli O111:B4; Sigma-Aldrich, St. Louis, MO) at time 0 h and again at 24 h post-administration. Before every sample was collected at least 3 mL of "waste" was aspirated through the extension tube and discarded. After every sample collection, 5 mL of saline solution was injected into the extension tube, followed by 3 mL of heparin. Whole blood samples were allowed to clot for 30 min and serum was collected after centrifugation at 1250 × g for 20 min at 4 o C. Serum was stored at −80ºC until analyzed for glucose, insulin, and NEFA concentrations.
At approximately 24 h post-LPS administration, steers were removed from the barn, BW were collected, and jugular catheters were removed. Unconsumed feed was collected and weighed, and a subsample of remaining feed was dried as described above to determine the DM content. The DMI, from d 52 to 56, by each individual steer was also calculated. A fi nal BW was collected 7 d later (d 63). Serum Analyses. Glucose concentrations were determined by modifi cation of the enzymatic Autokit Glucose (Wako Diagnostics, Richmond, VA) for a 96-well format. Briefl y, 300 μL of prepared Working Solution was added to 2 μL of serum or prepared standards in a 96-well plate. Plates were incubated at 37 o C for 5 min and then read using a plate reader at 505 nm. Concentration of glucose was determined by comparing unknown samples to a standard curve of known glucose concentrations. The minimum detectible concentration is 3.8 mg/dL and the intra-and inter-assay coeffi cients of variation were 7.9% and 6.9%, respectively. Data are presented as the concentration in mg/dL.
Insulin concentrations were determined by a bovinespecifi c insulin ELISA according to the manufacturer's instructions (Cat # 80-INSBO-E01; Alpco Diagnostics, Salem, NH). The minimum detectable concentration is 0.1 ng/mL and the intra-and inter-assay CV were 9.8% and 14.7%, respectively. Data are presented as the concentration in ng/mL.
Concentrations of NEFA were determined by modifi cation of the enzymatic HR Series NEFA-HR (2) assay (Wako Diagnostics, Richmond, VA) for a 96-well format. Briefl y, 200 μL of the prepared Color Reagent A were added to 5 μL of serum or prepared standards in a 96-well plate. Plates were incubated at 37 o C for 5 min and then read using a plate reader at 550 nm. Next, 100 μL of prepared Color Reagent B was added to the 96-well plate. Plates were incubated for an additional 5 min and read for a second time using a plate reader at 550 nm. Concentrations of NEFA were determined by comparing unknown samples to a standard curve of known NEFA concentrations. The minimum detectable concentration is 0.0014 mmol/L and the intra-and interassay CV were 10.7% and 11.3%, respectively. Data are presented as the concentration in mmol/L. Statistical Analyses. Glucose, insulin, and NEFA data were analyzed using the MIXED procedure of SAS (specifi c for repeated measures with treatment, time, and time × treatment interaction included as fi xed effects. Individual steer served as the experimental unit. A P-value of ≤ 0.05 was considered signifi cant, and 0.05 > P ≤ 0.10 was considered a tendency.
RESULTS AND DISCUSSION

Performance
Performance data are presented in Table 3 . Orthogonal contrasts detected no differences for BW, ADG, DMI, and G:F on d 0 or after the fi rst 14 d of the trial (P ≥ 0.14). Through d 28 the 2 greatest doses of Cr began to display advantages as evident by a tendency for a linear increase in DMI (P = 0.07) with increasing Cr supplementation. As a result, ADG also increased linearly (P = 0.04) with increasing Cr supplementation. This equated to a 12.6% increase in ADG in favor of Cr supplementation when comparing the greatest Cr-supplemented steers (0.3 mg/ kg) to the Con steers. This is supported by Chang and Mowat (1992) , who reported a 30% increase in ADG and a 27% increase in feed effi ciency after feeding 0.4 mg/kg of a high-Cr yeast for 28 d to steers that had not received an oxytetracycline injection. In contrast, the steers that had received an oxytetracycline injection 48 h after arrival did not display any advantages with Cr supplementation (Chang and Mowat, 1992) . Additionally, MoonsieShageer and reported that 0.2 mg/kg and 1.0 mg/kg of supplemental Cr as high-Cr yeast improved ADG by 27% in a 30 d study, likely as a result of increasing DMI. Mowat et al. (1993) concluded that chelated Cr improved daily BW gain by 41% during the fi rst 21 d, mainly due to reduced morbidity, but high-Cr yeast had no effect. Kegley et al. (2000) reported no differences in performance of cattle provided 0.4 or 0.8 mg/ kg of Cr-L-methionine for 21 to 23 d; however, it should be noted that these calves were on feed 21 d before the start of the study. From d 0 to 28, a quadratic response in G:F (P = 0.01) and d 28 BW (data not shown; P = 0.05) was observed, with 0.1 mg/kg of supplemental Cr being the least desirable and 0.3 mg/kg of supplemental Cr being the most accelerated. From d 0 to 42 ADG (P = 0.06) showed a tendency to increase linearly with increasing Cr concentration. Over the entire trial (d 0 to 56), ADG (P = 0.03) increased linearly and d 56 BW (P = 0.08) tended to increased linearly, as a result of G:F (P = 0.05) increasing linearly as Cr concentrations were increased, with 0.3 mg/kg of Cr being the most favorable treatment level. Kegley et al. (1997) reported 0.4 mg/kg of Cr supplemented as Cr-nicotinic acid complex tended to increase ADG over an 80-d period independent of shipping stress in steers. Alternatively, an earlier 56-d study by Kegley and Spears (1995) supplementing 0.4 mg/kg of Cr as CrCl 3 , high-Cr yeast, or Cr-nicotinic acid complex demonstrated no performance advantages for any Cr source, but there were also 0 incidences of morbidity implying that the cattle were not in a stressed state. Bunting et al. (1994) observed no differences in cattle feedlot performance when supplementing 0.37 mg/kg of Cr-picolinate for 56 or 58 d.
Additionally, contrasts were constructed between Con and 0.3 mg/kg of Cr from an a priori hypothesis. This contrast resulted in no differences in performance variables after the fi rst 14 d of feeding. By d 28, the 0.3 mg/ kg Cr-supplemented steers tended to have greater DMI and ADG (6.08 ± 0.23 and 1.70 ± 0.07 kg, respectively) when compared with the Con steers (5.67 ± 0.24 and 1.51 ± 0.08 kg, respectively; P < 0.09). Through 42 d, ADG tended to be greater for the 0.3 mg/kg Cr-supplemented steers (1.74 ± 0.07 kg) versus the Con steers (1.56 ± a,b Differing superscripts with a row represent differences at P < 0.05.
y,z Differing superscripts with a row represent differences at P ≤ 0.10.
0.07 kg; P = 0.09). Overall (d 0 to d 56), G:F (P = 0.10) tended to be improved for steers supplemented with 0.3 mg/kg Cr versus Con steers. This created a 10.8% increase in ADG (P = 0.04) in favor of the 0.3 mg/kg Crsupplemented steers (1.74 ± 0.6 kg) compared with Con steers (1.57 ± 0.6 kg). In the dairy industry, Cr in forms of Cr-methionine (Hayirli et al., 2001 and Smith et al., 2005) , Cr-propionate (McNamara and Valdez, 2005) , or chelated Cr (Yang et al., 1996) have been fairly consistent in improving DMI, milk yields, BW, reproductive performance, and/or reducing body condition losses. This study revealed that Cr-supplemented steers had improvements in DMI, feed effi ciency, and performance within 28 d on trial. Cattle would be under signifi cant nutritional and physiological stress during this period. Through the remainder of the trial, Cr-supplemented steers maintained or slightly increased these advantages in feedlot performance. Other Cr literature supports our fi ndings and some contradict our results (Chang and Mowat, 1992; Mowat et al., 1993; Kegley and Spears, 1995; Kegley et al., 1997 Kegley et al., , 2000 . These variations in Cr data could be attributed to disparities in stress levels of the cattle (which can result in temporary Cr defi ciencies), the basal Cr content of the diet, the concentration of Cr supplementation, and most importantly the source of Cr supplementation (Spears, 2000) . Our results indicated that the addition of 0.3 mg/kg Cr resulted in the greatest improvement in feed effi ciency and daily BW gain.
Morbidity
Morbidity data are presented in Table 4 . The number of steers treated at least once tended to linearly decrease with increasing Cr concentrations (P = 0.07). Supplementation with 0.3 mg/kg of Cr reduced the number of steers treated at least once when compared with Con steers (7.5 ± 4.2 vs. 25.9 ± 7.5%, respectively; P = 0.05). Also, the percentage of total cattle whose fi rst treatment was from d 0 to 14 for 0 mg/kg, 0.1 mg/kg, 0.2 mg/kg, and 0.3 mg/kg of Cr supplementation were 26, 18, 18, and 5 ± 7.3%, respectively (data not shown). The percentage of total cattle that were treated for the fi rst time during the fi rst 14 d linearly decreased as Crsupplementation increased (P = 0.03). Supplementation with 0.3 mg/kg of Cr reduced the number of steers whose fi rst treatment was from d 0 to 14 when compared with Con steers (5 ± 3.4 vs. 26 ± 7.3%, respectively; P = 0.03). Moonsie-Shageer and reported that Cr supplementation (0.2, 0.5, and 1.0 mg/kg of Cr) tend to reduced morbidity; with 0.2 mg/kg being a signifi cant improvement compared with other treatments through a 30 d trial. Mowat et al. (1993) reported that high-Cr yeast and chelated Cr reduced morbidity during a 35 d study. In a preliminary study by Lein et al. (2005) , 0.2 mg/kg of Cr-propionate supplemented to weanling pigs for 30 d signifi cantly reduced the mortality rate after a high dose intravenous LPS challenge (200 μg/kg). On the other hand, Cr supplementation at 0.2 mg/kg or 0.4 mg/kg of a high-Cr yeast did not affect morbidity in a study by Chang and Mowat (1992) . In the current study, no differences were identifi ed for cattle treated at least twice, and there were not enough observations to statistically analyze the number of cattle treated at least 3 times. The supplementation of 0.3 mg/kg Cr produced a relevant reduction in the number of morbid steers. This is an extremely important point because bovine respiratory disease and other illnesses cost the U.S. beef industry over $750 million annually (Griffi n, 1997) . No mortalities occurred during the trial.
LPS Challenge
At cannulation, steer BW did not differ between the Cr-supplemented (314 ± 8 kg) and Con steers (324 ± 8 kg; P = 0.37). From cannulation to 24 h post-LPS, steers lost BW independent of Cr treatment. Decreased performance would be a common sign of endotoxin-induced septicemia. Twenty-four hours post-LPS (4 d after cannulation BW measurement), Cr-supplemented steers had lost less BW (−7 ± 2 kg) than Con steers (−14 ± 2 kg; P = 0.03; Figure 1 ). Average daily DMI decreased during the 4 d metabolic study (d 52 to 56) when compared with the week before the metabolic study (P < 0.01), but there were no differences between treatments for DMI (P = 0.68; Figure 2 ). It is important to note that there was large animal-to-animal variation (independent of treatment) in DMI over the 4 d measuring period. Because DMI was measured over a 4-d period, any treatment differences that might have been present from 0 to 24 h post-LPS, could have been over shadowed by DMI measured the previous 3 d. There is no known previous research which has evaluated the effect of a LPS chal- lenge on newly-received steers supplemented with Cr. However, previous LPS research has consistently shown decreases in DMI after a LPS challenge (0.5 to 2.0 μg/ kg BW infused intravenously over 100 min; Steiger et al., 1999; Waldron et al., 2003; Waggoner et al., 2009 ). There was no difference between treatments in BW gain from 24 h post-LPS to 8 d post-LPS (P = 0.66; Figure 1 ). Overall, comparing cannulation BW to BW measured 8 d post-LPS, there was a tendency for a treatment effect (P = 0.09), with Con steers losing BW (−2.4 ± 3.6 kg) and Cr-supplemented steers gaining BW (6.4 ± 3.6 kg) in response to a LPS challenge. Lee et al. (2000) and van Heugten and Spears (1997) reported that the performance of weanling pigs was depressed after an intraperitoneal LPS injection (200 μg/kg BW), independent of Cr supplementation (0.4 mg/kg of Cr-picolinate and 0.2 mg/kg of either CrCl 3 , Cr-picolinate, or Cr-nicotinic acid complex, respectively). van Heugten and Spears (1997) also reported that intraperitoneal LPS injections (200 μg/kg BW) on d 7, 10, and 13 reduced the feed intake and G:F of weanling pigs from d 7 to16 independent of Cr supplementation. Before the LPS challenge, serum concentration of glucose was not affected by treatment (P = 0.96) or time (P = 0.11; Figure 3) . In response to LPS, there was a time × treatment interaction in that glucose concentrations increased and produced a peak at 0.5 h in Cr-supplemented steers (153 ± 4 mg/dL), but did not change in Con steers (111 ± 4 mg/dL; P < 0.01). Concentrations of glucose decreased in Cr-supplemented cattle from peak values at 0.5 h and in Con steers beginning at 2 h compared with baseline values (P < 0.01). Steiger et al. (1999) and Waggoner et al. (2009) both reported that a LPS challenge (2.0 and 1.5 μg/kg BW infused intravenously over 100 min, respectively) caused a signifi cant increase in glucose concentration within 1 to 2 h post-LPS infusion when compared with non-challenged cattle. In addition, they reported a sharp decrease in glucose concentration around 3 to 4 h post-LPS to concentrations less than those not challenged with LPS, which was maintained for 6 to 8 h. On the other hand, Waldron et al. (2003) reported no differences in glucose concentration between non-challenged and LPS-challenged lactating cows (0, 0.5, 1.0, and 1.5 μg/kg BW infused intravenously over 100 min). Although not signifi cantly different, glucose concentration of the cows in the aforementioned study receiving 1.5 μg/kg BW of LPS did decline to concentrations less than the non-challenged cows at 4 h post-LPS. Lee et al. (2000) reported no differences in glucose concentration between Con and Cr-supplemented weanling pigs after a LPS injection on d 21 or 35; but 8 h after the d 35 injection both treatments displayed a signifi cant decrease in circulating glucose concentrations. After an injection with LPS on d 28 and 56, Lein et al. (2005) concluded on differences in glucose concentrations between treatments of weanling pigs supplemented with Cr-propionate.
Serum insulin concentration was not affected by treatment (P = 0.63) or time (P = 0.68) before administration of LPS (Figure 4) . Post-LPS administration, The effect of chromium (Cr) supplementation on ADG and DMI in response to a lipopolysaccharide (LPS) challenge. Crossbred steers (n = 20; initial BW 235 ± 4 kg) were separated into 2 treatments receiving a diet that added 0 (Con; n = 10) or 0.2 mg/kg of Cr (KemTRACE Chromium Propionate 0.04%, Kemin Industries, Des Moines, IA; n = 10) to the diet on a DM basis for 56 d. Body weights were collected at cannulation and 24 h after a LPS challenge (0.5 μg/kg BW). Individual DMI were record. Steers supplemented with Cr displayed improved ADG (P = 0.02), but no differences in DMI (P = 0.68) when compared with Con steers. Data presented as LSM ± SEM.
concentrations of insulin increased, peaking within 2 h, before decreasing to baseline values (time: P < 0.01). The response of insulin concentrations after a LPS challenge has been very consistent in previous studies. After a LPS challenge (0.5 to 2.0 μg/kg BW of LPS infused intravenously over 100 min), insulin concentration peaked within 3 to 4 h post-LPS and returned to baseline 4 to 6 h post-LPS (Steiger et al., 1999; Waldron et al., 2003; Waggoner et al., 2009 ). In Con and Crsupplemented weaned pigs, insulin concentration signifi cantly increased 4 h after a d 21 LPS injection and returned to baseline values by 8 h post-LPS (Lee et al., 2000) . The peak in insulin concentration 3 to 4 h post-LPS in the aforementioned studies is delayed compared with the peak at 2 h that is reported in the present study. However, it is important to note that the previous studies injected or slowly-infused the LPS, whereas the present study infused a one-time LPS bolus in less than 1 min.
Serum concentrations of NEFA were not affected by treatment (P = 0.54), but tended to decrease over time (P = 0.10) before administration of LPS ( Figure 5 ). In response to LPS challenge, NEFA concentrations increased and peaked within 0.5 h (time: P < 0.01). Although there was no overall effect of treatment on NEFA concentrations (P = 0.66), Cr-supplemented steers produced a greater peak NEFA concentration (0.21 ± 0.02 mmol/L) at 0.5 h than Con steers (0.16 ± 0.02 mmol/L; P < 0.01). Waldron et al. (2003) reported that NEFA concentrations peaked 2 h after a LPS challenge (0.5 to 1.5 μg/ kg BW of LPS infused intravenously over 100 min), and returned to concentrations equivalent to non-challenged cattle at 3 h in lactating cows. Steiger et al. (1999) concluded that a LPS challenge (2 μg/kg BW of LPS infused intravenously over 100 min) caused a peak in circulating FFA concentration at 1 h post-LPS infusion, and FFA concentration returned to baseline by 3 h post-LPS in lightweight heifers. Subcutaneous injection of LPS (4 μg/kg BW) to 5 d old Jersey bull calves created an increase in circulating NEFA concentration 5 to 15 h post-LPS (Ballou et al., 2008) . The NEFA concentration of these bulls started to decline around 25 h post-LPS. Chromium-supplemented weanling pigs displayed an increase in circulating triglyceride concentration 2 h after a LPS injection on d 21 and 35 when compared with Con pigs (Lee et al., 2000) . Alternatively, supplementing Cr-propionate to weanling pigs had no effect on triglyceride concentrations after a LPS injection on d 28 and 56 (Lein et al., 2005) .
Data from the metabolic study indicated that Cr supplementation enhanced the glucose and NEFA response to a LPS challenge, but did not affect the insulin response. Non-supplemented steers tended to lose BW but the Cr-supplemented steers gained BW 8 d after the LPS challenge.
Conclusions
Currently, Cr-propionate is the only Cr source permitted for supplementation to cattle diets in the U.S. Supplementation of Cr-propionate, especially at 0.3 mg/ kg, can reduce costs associated with morbid cattle and improve the feed effi ciency and performance of steers fed during a 56-d receiving period. Crossbred steers (n = 20; initial BW 235 ± 4 kg) were separated into 2 treatments receiving a diet that added 0 (Con; n = 10) or 0.2 mg/kg of Cr (KemTRACE Chromium Propionate 0.04%, Kemin Industries, Des Moines, IA; n = 10) to the diet on a DM basis for 56 d. Blood samples were collected at 0.5 h intervals from −2 to 8 h and at 24 h relative to a LPS challenge (0.5 μg/kg BW) at time 0 h. Serum was isolated and analyzed for glucose concentrations. Concentrations of serum glucose increased in response to a LPS challenge in only the Cr-supplemented steers, resulting in a time × treatment interaction (P < 0.01). Data presented as LSM ± SEM. Treatment means differ: *P < 0.05. Crossbred steers (n = 20; initial BW 235 ± 4 kg) were separated into 2 treatments receiving a diet that added 0 (Con; n = 10) or 0.2 mg/kg of Cr (KemTRACE Chromium Propionate 0.04%, Kemin Industries, Des Moines, IA; n = 10) to the diet on a DM basis for 56 d. Blood samples were collected at 0.5 h intervals from −2 to 8 h and at 24 h relative to a LPS challenge (0.5 μg/kg BW) at time 0 h. Serum was isolated and analyzed for insulin concentrations. Post-LPS serum insulin concentrations peaked within 2 h. Data presented as LSM ± SEM. Treatment means differ: *P < 0.05
